Genetic and Genomic Medicine in Rare Disease Care | CIS/BRICS Forum on Rare Diseases 2026

Genetic and genomic medicine is becoming a cornerstone of rare disease care. This international session was held as part of the 3rd CIS/BRICS Forum on Rare Diseases 2026 and focused on the role of genetic and genomic technologies in improving diagnosis, clinical pathways, and access to care for patients with rare diseases. Experts from the UAE, Russia, Belarus, Kazakhstan, Uzbekistan, Georgia, Pakistan, and Türkiye discussed how different healthcare systems are developing genetic services for rare diseases, including newborn screening, molecular diagnostics, clinical interpretation of genetic data, and integration of genomic medicine into patient care. Session: International experience in genetic technologies for rare disease care Forum: 3rd CIS/BRICS Forum on Rare Diseases 2026 Date: May 26, 2026 Format: Online Organiser: CIS Orphan Consortium Moderators: Dr. Ayman El-Hattab — Burjeel Medical City, UAE Prof. Gulnara Svyatova - Centre for Molecular Medicine, Kazakhstan Speakers: Sergey Voronin - Research Centre for Medical Genetics, Russia Oksana Pribushenya - RSPC "Mother and Child", Belarus Markhabo Shamsiddinova — Republican Specialized Scientific-Practical Medical Centre for Mother and Child Health, Uzbekistan Ambrin Fatima — Aga Khan University, Pakistan Fatmagül Atalar — Istanbul University, Türkiye Lali Margvelashvili — Centre for Medical Genetics and Laboratory Diagnostics, Georgia The session highlights the importance of international cooperation for CIS and BRICS countries in the field of rare disease diagnostics, genetic testing, genomic medicine, workforce development, laboratory infrastructure, and patient access to specialised care. CIS Orphan Consortium brings together experts and organisations working to improve rare disease care, access to diagnostics, treatment pathways, and international collaboration across CIS, BRICS, and partner countries.